Abstract

AbstractBreast cancer is one of the leading causes of death among women worldwide. In most cases, the misinterpretation of medical diagnosis plays a vital role in increased fatality rates due to breast cancer. Breast cancer can be diagnosed by classifying tumors. There are two different types of tumors, such as malignant and benign tumors. Identifying the type of tumor is a tedious task, even for experts. Hence, an automated diagnosis is necessary. The role of machine learning in medical diagnosis is eminent as it provides more accurate results in classifying and predicting diseases. In this paper, we propose a deep ensemble network (DEN) method for classifying and predicting breast cancer. This method uses a stacked convolutional neural network, artificial neural network and recurrent neural network as the base classifiers in the ensemble. The random forest algorithm is used as the meta‐learner for providing the final prediction. Experimental results show that the proposed DEN technique outperforms all the existing approaches in terms of accuracy, sensitivity, specificity, F‐score and area under the curve (AUC) measures. The analysis of variance test proves that the proposed DEN model is statistically more significant than the other existing classification models; thus, the proposed approach may aid in the early detection and diagnosis of breast cancer in women, hence aiding in the development of early treatment techniques to increase survival rate.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.